Label it All: Kem Medical is Made for Sterile Processing

This episode of the ConCensis podcast looks into the critical world of sterile processing with CtUC 2023 platinum sponsor Kem Medical Products Corp. Host Vanessa Cavanaugh and guest Mark Ebenstein, VP of Products and Services at Kem Medical, discuss the tools and strategies that ensure safety in healthcare environments. Together, they explore Kem Medical’s integral contributions to sterile processing and Ebenstein’s journey within the industry.

The conversation reveals Kem Medical’s comprehensive range of products designed for sterile and surgical environments, from monitoring badges to neutralizing solutions and spill kits. Ebenstein shares his insights on transitioning from a large corporation to a smaller, more hands-on company and the importance of specialized products for sterile processing departments. Listeners and viewers will get an insider’s perspective on the challenges and solutions that Kem Medical provides, ensuring the safety of healthcare workers and patients.

Recent Episodes

Healthcare leadership is being redefined in real time. With the rise of AI, mounting financial pressures, and workforce burnout, executives today are operating in an environment of continuous disruption and uncertainty. In fact, industry leaders now rank workforce shortages and digital transformation among their top concerns—forcing a new kind of leadership that blends decisiveness…

Healthcare systems are facing a workforce crisis that’s no longer temporary—it’s structural. Even before COVID-19, staffing shortages across nursing, technical, and administrative roles were already straining capacity; today, those gaps are wider, costlier, and directly impacting patient access. With labor shortages persisting and burnout rising, health systems are being forced to rethink not just…

Healthcare systems are entering 2026 under mounting pressure. A growing, aging population and rising disease burden are colliding with persistent workforce shortages—highlighted by projections that new cancer diagnoses in the U.S. will surpass two million this year alone. The stakes are no longer theoretical: delays in care, limited specialist access, and widening disparities are…